Algofunctional Index Hip

1. Abstract

The Algofunctional Index Hip (in French and international clinical literature, the Lequesne Index of Severity for Osteoarthritis of the Hip [LISOH] or Indice Algo-Fonctionnel de Lequesne pour la hanche; in Dutch, the Algofunctionele Index heup [AFI-heup]) is an established, disease-specific patient-reported outcome measure (PROM) designed to quantify symptom severity, pain intensity, and physical functional limitations in individuals suffering from coxarthrosis (hip osteoarthritis). Developed initially by French rheumatologist Michel Lequesne in 1987 and subsequently validated across multiple language versions, including the Dutch adaptation by Wilfred F. H. Peter and colleagues (2010), the index addresses the combined burden of joint pain and functional impairment. The instrument consists of 10 primary items structured across three clinically distinct domains: (1) Pain or discomfort during rest, posture maintenance, and movement (5 items, scoring 0–8 points); (2) Maximum distance walked, incorporating endurance and the conditional utilization of walking aids (1 comprehensive compound item, scoring 0–8 points); and (3) Activities of daily living (ADL) involving hip articulation and flexion, including foot care, stair climbing, picking up objects, and transferring from deep seating or automobiles (4 items, scoring 0–8 points). The cumulative composite score ranges from 0 (denoting an absence of pain and disability) to 24 (representing maximal, catastrophic algofunctional impairment). Psychometric investigations across diverse clinical populations demonstrate robust measurement properties, including high internal consistency (Cronbach’s alpha ranging from .72 to .88 across subscales and composite measures), exceptional test-retest reliability (intraclass correlation coefficients [ICC] typically exceeding .85 to .95), and strong construct and convergent validity when benchmarked against the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Short Form Health Survey (SF-36), and performance-based ambulatory tests. Consequently, the Algofunctional Index Hip remains a cornerstone evaluative instrument in orthopedic trials, rheumatological observational studies, and clinical assessment protocols for surgical decision-making in total hip arthroplasty (THA).

2. Keywords

Algofunctional Index Hip, Lequesne Index, hip osteoarthritis, coxarthrosis, patient-reported outcome measure, physical disability, joint pain, functional impairment, psychometrics, total hip arthroplasty, clinical rheumatology, orthopedics.

3. Authors

The original conceptualization and psychometric development of the Algofunctional Index for Hip Osteoarthritis were conducted by Michel G. Lequesne, MD, a renowned clinical rheumatologist and former head of the Department of Rheumatology at Hôpital Léopold Bellan in Paris, France, in collaboration with international rheumatology study groups under the auspices of the European League Against Rheumatism (EULAR). The official cross-cultural translation, adaptation, and psychometric validation of the Dutch version (Algofunctionele Index heup) were spearheaded by Wilfred F. H. Peter, PT, PhD, along with co-investigators Thea P. M. Vlieland, Leo D. Roorda, and their colleagues associated with the Department of Rheumatology at Leiden University Medical Center (LUMC) and the Amsterdam Rehabilitation Research Center | Reade in the Netherlands.

4. Purpose

The primary clinical and psychometric purpose of the Algofunctional Index Hip is to provide an objective, standardized, and easily interpretable index of disease severity that synthesizes two interconnected clinical manifestations of hip osteoarthritis: nociceptive pain experience and biomechanical functional limitation. Osteoarthritis of the hip is fundamentally a progressive, degenerative articular disorder characterized by cartilage breakdown, subchondral bone remodeling, osteophyte formation, and secondary synovial inflammation. While radiological imaging—such as plain radiography quantified via the Kellgren-Lawrence grading system—documents structural joint degeneration, radiographic pathology frequently exhibits a marked clinico-radiological dissociation. Many individuals with severe joint space narrowing report manageable discomfort, whereas others with mild structural changes endure debilitating symptoms. The Algofunctional Index was established to quantify the true phenotypic burden experienced by the patient in daily life.

In clinical practice, the tool serves multiple diagnostic, prognostic, and evaluative purposes. It is widely employed as a decision-support metric when determining the necessity, timing, and appropriateness of conservative therapeutic interventions—including non-steroidal anti-inflammatory drugs (NSAIDs), targeted physical therapy, hydrotherapy, and weight management—versus surgical interventions such as joint-preserving osteotomies or total hip arthroplasty (THA). A composite score surpassing designated clinical thresholds (historically ≥ 10 to 12 points) is frequently cited in European rheumatology guidelines as indicating severe or extremely severe handicap warranting surgical consultation.

In research contexts, the instrument functions as an established primary or secondary endpoint in randomized controlled trials (RCTs) investigating disease-modifying osteoarthritis drugs (DMOADs), intra-articular therapies, rehabilitation protocols, and surgical implant designs. Its brevity, ease of self-administration or brief interview completion, and direct translation into a 24-point linear scale make it pragmatic for large-scale registry surveillance, longitudinal observational cohort studies, and routine clinical health informatics.

5. Psychological Construct

The Algofunctional Index Hip operationalizes a multidimensional biobehavioral construct: osteoarthritic algofunctional disability. This construct represents the complex intersection between peripheral nociceptive signaling, pain perception, movement avoidance, and biomechanical performance deficits during everyday motor tasks. The instrument deconstructs this overarching construct into three interrelated behavioral and experiential domains:

1. Pain or Discomfort (Items 1–5)

This subscale assesses subjective nociceptive intensity across divergent physiological states and mechanical loading paradigms. It explicitly differentiates between:

• Nocturnal / Rest Pain (Item 1): Unprovoked nocturnal pain or pain occurring without movement reflects severe joint congestion, capsular distension, or intraosseous hypertension, often indicative of advanced inflammatory exacerbation within the osteoarthritic joint.
• Morning Stiffness and Regressive Pain (Item 2): Morning gelling phenomena, where joint stiffness and dull aching persist upon waking, serving as an index of synovial fluid viscidity and soft-tissue contracture.
• Static Mechanical Load Pain (Item 3): Prolonged static standing (30 minutes) measures the hip joint’s capacity to maintain sustained axial load without dynamic muscle pump action or synovial fluid redistribution.
• Dynamic Ambulation Pain (Item 4): Pain occurring during uninterrupted walking captures mechanical cartilage friction, subchondral microfractures, and load-induced periarticular strain.
• Kinetic Transition Discomfort (Item 5): Rising from a seated position without upper-limb assistance places an acute mechanical torque and high joint contact force across the femoral head and acetabulum, testing maximal instantaneous hip extensor capacity and joint tolerance.

2. Maximum Walking Distance and Ambulatory Endurance (Item 6)

Ambulatory capacity is an essential determinant of personal autonomy and community engagement. The scale stratifies walking tolerance along a discrete distance gradient ranging from unrestricted (> 1 km) down to critical confinement (< 100 meters). Importantly, the construct captures physiological compensation and external support: respondents receive additive impairment weighting if their mobility necessitates the use of a unilateral or bilateral walking aid (e.g., cane, crutch). This structural integration reflects the psychophysical reality that assistive devices mitigate pain at the cost of functional independence.

3. Activities of Daily Living Involving the Lower Extremities (Items 7–10)

This domain captures specific motor behaviors that demand significant hip flexion, internal/external rotation, and adduction/abduction. Performing these self-care and navigational tasks requires coordinated neuromuscular control across a compromised range of motion:

• Putting on footwear (Item 7): Requires deep anterior hip flexion and rotational flexibility while reaching forward.
• Floor retrieval (Item 8): Necessitates deep unilateral or bilateral hip flexion, pelvic tilting, and core stability to counteract gravitational torque.
• Ascending and descending stairs (Item 9): Imposes high eccentric and concentric joint contact forces, demanding substantial quadriceps, gluteal, and hip stabilizer activation.
• Vehicle or deep chair ingress/egress (Item 10): Combines low-angle sitting with torsional rotation during transfer, which regularly triggers impingement of anterior osteophytes or labral stress.

6. Theoretical Framework

The theoretical framework underpinning the Algofunctional Index Hip is directly aligned with the World Health Organization’s International Classification of Functioning, Disability and Health (ICF), as well as the classic disablement models formulated by Saad Nagi and later expanded by Verbrugge and Jette. Within this paradigm, the progression from articular pathology to full-scale handicap is understood not as a linear mechanical event, but as a dynamic interaction among structural impairments, activity limitations, and environmental demands.

Under the ICF framework, the primary anatomical damage (cartilage fibrillation, joint space narrowing, subchondral sclerosis) constitutes the body functions and structures level. The Lequesne index specifically evaluates the secondary consequence: the emergence of impairments (pain during movement, static load intolerance, morning stiffness) and their direct translation into activity limitations (inability to walk continuous distances, climb stairs, or bend down to put on shoes). Because the instrument deliberately weights both subjective distress (pain) and observable performance decrement (distance walked and ADL completion), it embodies the premise that pain in musculoskeletal disorders cannot be understood separately from its functional sequelae.

Furthermore, the instrument reflects tenets of behavioral kinesiology and the fear-avoidance model of chronic musculoskeletal pain. When movement triggers acute mechanical nociception, patients systematically adopt compensatory behaviors—shortening their step length, curtailing ambulatory radius, and relying on external walking aids. Over time, physical deconditioning and capsuloligamentous contracture accelerate, producing a downward spiral of declining functional capacity. By capturing these specific behavioral milestones, the index reflects the functional adaptation of the individual within their physical environment.

7. Validity

The psychometric validity of the Algofunctional Index Hip has been thoroughly investigated across international cohorts, yielding robust evidence of construct, criterion, and responsiveness validity:

Construct and Convergent Validity

Numerous studies have confirmed strong convergent validity between the Lequesne Algofunctional Index and other validated osteoarthritis-specific outcome tools. Strong, statistically significant Pearson and Spearman correlation coefficients have been consistently documented between the Algofunctional Index Hip and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Specifically, the total Lequesne score correlates strongly with the WOMAC physical function subscale (r = .75 to .87) and the WOMAC pain subscale (r = .68 to .82). Moderate to strong correlations are observed when comparing the scale against generic health-related quality of life metrics, notably the Physical Component Summary (PCS) of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36; r = -.55 to -.70), whereas correlations with the Mental Component Summary (MCS) are uniformly lower (r = -.15 to -.30), demonstrating clear discriminant validity.

Criterion and Clinico-Radiological Validity

When evaluated against objective biomechanical benchmarks, the index exhibits strong concurrent validity. Walking distance categories correlate closely with instrumented gait analysis, 6-minute walk test (6MWT) outcomes, and timed up-and-go (TUG) test durations. When contrasted with radiographic staging using the Kellgren-Lawrence scale, moderate correlations (Spearman’s rho = .35 to .48) are found; this moderate magnitude is consistent with the well-documented clinico-radiological paradox in joint disease, confirming that the tool measures phenotypic functional burden rather than pure structural calcification.

Responsiveness and Longitudinal Sensitivity to Change

The instrument is sensitive to both therapeutic improvements and progressive functional deterioration. In prospective cohorts undergoing total hip arthroplasty, the index exhibits standardized response means (SRM) and effect sizes (Cohen’s d) ranging between 1.2 and 2.4 at 6 to 12 months postoperatively, confirming its sensitivity as an evaluative metric in surgical registries. Following conservative pharmacological trials (e.g., intra-articular corticosteroid or hyaluronic acid injections), the index reliably detects moderate treatment effects with SRMs ranging from 0.45 to 0.70.

8. Reliability

The reliability of the Algofunctional Index Hip has been established across multiple language versions, including French, English, Dutch, German, and Spanish, demonstrating stability and measurement precision:

Internal Consistency

Internal consistency analyses across clinical cohorts yield Cronbach’s alpha values typically falling within the acceptable to excellent psychometric range. In the Dutch validation study conducted by Peter et al. (2010), Cronbach’s alpha for the composite index was reported at .78 to .84 in patients presenting with primary hip osteoarthritis. Subscale internal consistency estimates generally range from .70 to .82 for the Pain domain and .74 to .86 for the Activities of Daily Living domain. The slightly lower alpha sometimes noted for the Walking Distance domain is expected, as it is composed of a single multidimensional compound item.

Test-Retest Reliability and Absolute Measurement Error

In stable patient populations assessed over test-retest intervals spanning 48 hours to 14 days, the intraclass correlation coefficient (ICC, two-way random effects, absolute agreement) for the total score ranges between .85 and .96. Subscale ICCs consistently exceed .80. In terms of absolute measurement error:

• The Standard Error of Measurement (SEM) is approximately 1.0 to 1.4 points on the 24-point scale.
• The Smallest Detectable Change (SDC) or Minimal Detectable Change at the 95% confidence interval (MDC₉₅) is estimated at approximately 2.8 to 3.8 points.
• The Minimal Clinically Important Difference (MCID) or Minimal Important Change (MIC) has been empirically defined across surgical and conservative cohorts as a reduction of at least 2.0 to 3.0 points (or approximately a 15% to 20% relative improvement from baseline).

9. Factor Analysis

Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have been performed on the Algofunctional Index Hip to evaluate its dimensionality and internal structural validity:

Exploratory Factor Structure

Principal component analyses and maximum likelihood extractions with oblique (Promax or Oblimin) rotation generally reveal a robust two-factor or three-factor latent structure that closely mirrors Lequesne’s clinical categorization:

• Factor 1: Dynamic Physical Function and ADL: Subsumes items 7, 8, 9, and 10 (socks, floor pickup, stairs, car/chair egress), with primary factor loadings typically ranging from .64 to .85. Item 6 (maximum walking distance) frequently cross-loads onto this factor (.55 to .70) or forms an independent single-indicator ambulatory factor.
• Factor 2: Nociceptive Symptom Burden / Pain: Subsumes items 1, 2, 3, 4, and 5 (nocturnal pain, morning stiffness, static standing pain, walking pain, and rising pain), displaying primary factor loadings between .52 and .79.

Confirmatory Factor Models and Model Fit

Confirmatory factor analyses testing a correlated three-factor model (Pain, Walking Distance, ADL) demonstrate acceptable to good goodness-of-fit indices across published empirical evaluations:

• Comparative Fit Index (CFI) ≥ .92 to .96
• Tucker-Lewis Index (TLI) ≥ .90 to .95
• Root Mean Square Error of Approximation (RMSEA) ≤ .05 to .07 (90% CI: .04–.08)
• Standardized Root Mean Square Residual (SRMR) ≤ .06

While a second-order unidimensional model (where a single higher-order “Algofunctional Severity” latent construct drives the three sub-dimensions) exhibits slightly lower fit statistics, it remains statistically justifiable, supporting the clinical convention of summing items into a single global score (0–24).

10. Instrument / Measurement Tool

The operational administration, architecture, and scoring metrics of the Algofunctional Index Hip are structured as follows:

• Instrument Name: Algofunctional Index Hip (Lequesne Index of Severity for Osteoarthritis of the Hip [LISOH] / Algofunctionele Index heup [AFI-heup])
• Primary Developer: Michel G. Lequesne (1987); Dutch validation: Wilfred F. H. Peter et al. (2010)
• Assessment Type: Clinician-administered structured interview or patient-reported outcome measure (PROM) questionnaire
• Target Population: Adults and elderly individuals with unilateral or bilateral hip osteoarthritis (coxarthrosis), post-traumatic hip degeneration, or candidate status for hip arthroplasty
• Number of Items: 10 distinct items (yielding 3 section subscores and 1 composite total score)
• Structural Sections:
  • Section I: Pain or discomfort (5 items; items 1–5; score range: 0–8 points)
  • Section II: Maximum distance walked (1 item with assistive device modifier; item 6; score range: 0–8 points)
  • Section III: Activities of daily living (4 items; items 7–10; score range: 0–8 points)
• Response Format: Item-specific weighted scoring (scores ranging from 0 to 1, 0 to 2, or 0 to 6 per item depending on severity; total index ranges from 0 to 24 points).
• Scoring Rules and Total Score Interpretation:
  • Cumulative Total Score: Sum of Sections I, II, and III (theoretical range: 0 to 24 points). Higher scores correspond directly to greater pain intensity and more severe functional disability.
  • Score 0: No handicap / asymptomatic
  • Score 1 to 4: Minor handicap
  • Score 5 to 7: Moderate handicap
  • Score 8 to 10: Severe handicap
  • Score 11 to 13: Very severe handicap
  • Score ≥ 14: Extremely severe handicap (often viewed as a major clinical indicator for total hip arthroplasty consideration)

11. Permissions & Fee and Test Year

The original Lequesne Algofunctional Index for Hip Osteoarthritis was published in 1987 in the Scandinavian Journal of Rheumatology. The Dutch cultural adaptation and psychometric validation were finalized and published in 2010. Under international copyright conventions and medical research standards, the original scale is considered in the public domain for non-commercial scientific research, academic inquiry, and routine clinical care. No licensing fees, royalties, or formal administrative registration are required for public health institutions or individual clinicians implementing the instrument.

Commercial entities, pharmaceutical trial sponsors, and software vendors integrating the scale into proprietary digital health or electronic clinical outcome assessment (eCOA) platforms are advised to consult the original publishers and ensure proper citation of the foundational validation publications (Lequesne, 1987; Peter et al., 2010). Any translation, adaptation, or computerized modification must preserve the weighted scoring algorithms and item phrasing to maintain measurement integrity.

12. References

Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., & Stitt, L. W. (1988). Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology, 15(12), 1833–1840.

Faucher, M., Poiraudeau, S., Lefevre-Colau, M. M., Rannou, F., Fermanian, J., & Revel, M. (2004). Assessment of the test-retest reliability and construct validity of a modified Lequesne index in patients with hip osteoarthritis. Joint Bone Spine, 71(2), 121–127. https://doi.org/10.1016/S1297-319X(03)00146-2

Lequesne, M. G. (1997). The algofunctional indices for hip and knee osteoarthritis. The Journal of Rheumatology, 24(4), 779–781.

Lequesne, M. G., Mery, C., Samson, M., & Gerard, P. (1987). Indexes of severity for osteoarthritis of the hip and knee: Validation-value in comparison with other assessment tests. Scandinavian Journal of Rheumatology. Supplement, 65, 85–89. https://doi.org/10.3109/03009748709102182

Peter, W. F. H., Loos, M., de Vet, H. C. W., Dekker, J., Verbunt, J. A., & Vlieland, T. P. M. (2010). Cross-cultural adaptation and psychometric evaluation of the Dutch version of the Lequesne Algofunctional Index for osteoarthritis of the hip and knee. Physical Therapy, 90(9), 1335–1347.

Tubach, F., Ravaud, P., Baron, G., Falissard, B., Logeart, I., Bellamy, N., Bombardier, C., Felson, D., Hochberg, M., & Dougados, M. (2005). Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: The minimal clinically important improvement. Annals of the Rheumatic Diseases, 64(1), 29–33. https://doi.org/10.1136/ard.2004.022905

World Health Organization. (2001). International Classification of Functioning, Disability and Health: ICF. World Health Organization.

13. Items of the Scale (Questionnaire)